Mimedx (MDXG) Market Capitalization (2010 - 2026)

Mimedx has disclosed Market Capitalization across 17 years of filings, most recently posting $561.0 million for Q2 2026.

• In Q2 2026, Market Capitalization fell 37.93% year-over-year to $561.0 million; the TTM figure through Jun 2026 stood at $561.0 million (down 37.93% YoY), while the FY2025 annual figure was $1.0 billion, down 29.07% from the prior year.
• Market Capitalization came in at $561.0 million for Q2 2026 at Mimedx, down from $588.3 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $1.4 billion in Q4 2024 to a low of $316.1 million in Q4 2022.
• Average Market Capitalization over 5 years is $791.5 million, with a median of $858.4 million recorded in 2023.
• Year-over-year, Market Capitalization plunged 71.83% in 2022 and jumped 223.21% in 2023.
• Over 5 years, Market Capitalization stood at $316.1 million in 2022, then jumped by 223.21% to $1.0 billion in 2023, then soared by 38.35% to $1.4 billion in 2024, then fell by 29.07% to $1.0 billion in 2025, then slumped by 44.04% to $561.0 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $561.0 million in Q2 2026, $588.3 million in Q1 2026, and $1.0 billion in Q4 2025.